Literature DB >> 19621353

Lysophosphatidic acid in vascular development and disease.

Siew T Teo1, Yun C Yung, Deron R Herr, Jerold Chun.   

Abstract

Lysophosphatidic acid (LPA) is a small signaling lipid that is capable of stimulating a plethora of different cellular responses through the activation of its family of cognate G protein-coupled receptors. LPA mediates a wide range of biological effects in many tissue types that have been recently reviewed; however, its effects on vasculature development and function have received comparatively less examination. In this review, literature on the actions of LPA in three main aspects of vascular development (vasculogenesis, angiogenesis, and vascular maturation) is discussed. In addition, evidence for the roles of LPA signaling in the formation of secondary vascular structures, such as the blood brain barrier, is considered, consistent with significant roles for LPA signaling in vascular development, function, and disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621353      PMCID: PMC4307796          DOI: 10.1002/iub.220

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  78 in total

Review 1.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

2.  The mouse lp(A3)/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern.

Authors:  J J Contos; J Chun
Journal:  Gene       Date:  2001-04-18       Impact factor: 3.688

3.  GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Authors:  Chang-Wook Lee; Richard Rivera; Shannon Gardell; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

4.  Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction.

Authors:  O Kranenburg; M Poland; F P van Horck; D Drechsel; A Hall; W H Moolenaar
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

5.  Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.

Authors:  J J Contos; N Fukushima; J A Weiner; D Kaushal; J Chun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

6.  Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of In vitro fertilization patients.

Authors:  A Tokumura; M Miyake; Y Nishioka; S Yamano; T Aono; K Fukuzawa
Journal:  Biol Reprod       Date:  1999-07       Impact factor: 4.285

7.  Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration.

Authors:  T S Panetti; J Nowlen; D F Mosher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

8.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

9.  Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.

Authors:  Manikandan Panchatcharam; Sumitra Miriyala; Fanmuyi Yang; Mauricio Rojas; Christopher End; Christopher Vallant; Anping Dong; Kevin Lynch; Jerold Chun; Andrew J Morris; Susan S Smyth
Journal:  Circ Res       Date:  2008-08-14       Impact factor: 17.367

10.  Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.

Authors:  Soon Young Park; Kang Jin Jeong; Jangsoon Lee; Dae Sung Yoon; Wahn Soo Choi; Yong Kee Kim; Jeung Whan Han; Yoon Mee Kim; Bum Kyeong Kim; Hoi Young Lee
Journal:  Cancer Lett       Date:  2007-10-04       Impact factor: 8.679

View more
  30 in total

1.  Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development.

Authors:  Hui Li; Zhenwen Zhao; Gang Wei; Libo Yan; Dongmei Wang; Hong Zhang; George Earl Sandusky; John Turk; Yan Xu
Journal:  FASEB J       Date:  2010-06-08       Impact factor: 5.191

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia.

Authors:  Tara Sudhadevi; Alison W Ha; David L Ebenezer; Panfeng Fu; Vijay Putherickal; Viswanathan Natarajan; Anantha Harijith
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-03-10       Impact factor: 4.698

4.  Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vessels.

Authors:  Sarah Melissa P Jacobo; Andrius Kazlauskas
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

5.  Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.

Authors:  Chanygi Chen; Lyssa N Ochoa; Anna Kagan; Hong Chai; Zhengdong Liang; Peter H Lin; Qizhi Yao
Journal:  Atherosclerosis       Date:  2012-02-13       Impact factor: 5.162

6.  Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.

Authors:  Makoto Kurano; Kuniyuki Kano; Tomotaka Dohi; Hirotaka Matsumoto; Koji Igarashi; Masako Nishikawa; Ryunosuke Ohkawa; Hitoshi Ikeda; Katsumi Miyauchi; Hiroyuki Daida; Junken Aoki; Yutaka Yatomi
Journal:  J Lipid Res       Date:  2016-12-22       Impact factor: 5.922

Review 7.  Lysophosphatidic acid signalling in development.

Authors:  Xiaoyan Sheng; Yun C Yung; Allison Chen; Jerold Chun
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

8.  Protection by D609 through cell-cycle regulation after stroke.

Authors:  Rao Muralikrishna Adibhatla; James F Hatcher
Journal:  Mol Neurobiol       Date:  2010-02-12       Impact factor: 5.590

9.  Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.

Authors:  Russell R Braeuer; Maya Zigler; Takafumi Kamiya; Andrey S Dobroff; Li Huang; Woonyoung Choi; David J McConkey; Einav Shoshan; Aaron K Mobley; Renduo Song; Avraham Raz; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

10.  Simple enrichment and analysis of plasma lysophosphatidic acids.

Authors:  Jialu Wang; Martha Sibrian-Vazquez; Jorge O Escobedo; Mark Lowry; Lei Wang; Yu-Hsuan Chu; Richard G Moore; Robert M Strongin
Journal:  Analyst       Date:  2013-11-21       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.